These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 20832557)
21. Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study. Gerth HU; Pohlen M; Thölking G; Pavenstädt H; Brand M; Wilms C; Hüsing-Kabar A; Görlich D; Kabar I; Schmidt HH PLoS One; 2017; 12(4):e0175529. PubMed ID: 28403210 [TBL] [Abstract][Full Text] [Related]
22. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091 [TBL] [Abstract][Full Text] [Related]
23. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Lee KH; Lee MK; Sutedja DS; Lim SG Liver Int; 2005 Oct; 25(5):973-7. PubMed ID: 16162155 [TBL] [Abstract][Full Text] [Related]
24. Early postoperative renal dysfunction in the adult living donor liver transplantation. Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177 [TBL] [Abstract][Full Text] [Related]
25. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480 [TBL] [Abstract][Full Text] [Related]
26. Indication for splenectomy in the era of living-donor liver transplantation. Jeng LB; Lee CC; Chiang HC; Chen TH; Hsu CH; Cheng HT; Lai HC Transplant Proc; 2008 Oct; 40(8):2531-3. PubMed ID: 18929791 [TBL] [Abstract][Full Text] [Related]
28. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Pugliese F; Ruberto F; Perrella SM; Cappannoli A; Bruno K; Martelli S; Celli P; Summonti D; D'Alio A; Tosi A; Novelli G; Morabito V; Poli L; Rossi M; Berloco PB; Pietropaoli P Transplant Proc; 2007; 39(6):2042-4. PubMed ID: 17692688 [TBL] [Abstract][Full Text] [Related]
29. Is MARS system enough for A. phalloides-induced liver failure treatment? Sorodoc L; Lionte C; Sorodoc V; Petris O; Jaba I Hum Exp Toxicol; 2010 Oct; 29(10):823-32. PubMed ID: 20179021 [TBL] [Abstract][Full Text] [Related]
30. Indications for and survival after liver retransplantation. Bellido CB; Martínez JM; Gómez LM; Artacho GS; Diez-Canedo JS; Pulido LB; Acevedo JM; Bravo MA Transplant Proc; 2010 Mar; 42(2):637-40. PubMed ID: 20304211 [TBL] [Abstract][Full Text] [Related]
31. Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Hommann M; Kasakow LB; Geoghegan J; Kornberg A; Schotte U; Fuchs D; Hermann J; Zintl F; Scheele J Pediatr Transplant; 2002 Aug; 6(4):340-3. PubMed ID: 12234277 [TBL] [Abstract][Full Text] [Related]
32. One hundred sixteen cases of acute liver failure treated with MARS. Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742 [TBL] [Abstract][Full Text] [Related]
33. Plasmapheresis: an effective therapy for primary allograft nonfunction after liver transplantation. Mandal AK; King KE; Humphreys SL; Maley WR; Burdick JF; Klein AS Transplantation; 2000 Jul; 70(1):216-20. PubMed ID: 10919607 [TBL] [Abstract][Full Text] [Related]
34. Adult ABO-incompatible liver transplantation, using A and B donors. Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811 [TBL] [Abstract][Full Text] [Related]
35. Long-term experience of plasmapheresis in antibody-mediated rejection in renal transplantation. Brown CM; Abraham KA; O'Kelly P; Conlon PJ; Walshe JJ Transplant Proc; 2009 Nov; 41(9):3690-2. PubMed ID: 19917368 [TBL] [Abstract][Full Text] [Related]
36. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Thuluvath PJ; Yoo HY Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301 [TBL] [Abstract][Full Text] [Related]
37. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list. Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112 [TBL] [Abstract][Full Text] [Related]